methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

C83H94N18O10 — CID 91013429

IUPACmethyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
SMILESCOC(=O)NC(C(=O)NC(C)c1nc2cc(-c3ccc(-c4ccc5nc(C6CCCN6C(=O)C(c6ccccc6)N(C)C)[nH]c5c4)cc3)c(COC(=O)NC(C(=O)N3CCCC3c3nc4ccc(-c5cnc(-c6ccc7nc(C8CCCN8C(=O)C(NC(=O)OC)C(C)C)[nH]c7c6)cn5)cc4[nH]3)C(C)C)cc2[nH]1)C(C)C
InChIInChI=1S/C83H94N18O10/c1-44(2)69(95-81(106)109-10)77(102)86-47(7)73-90-62-39-54(55(40-63(62)91-73)49-25-23-48(24-26-49)51-27-30-56-59(36-51)92-76(87-56)68-22-17-35-101(68)80(105)72(98(8)9)50-18-13-12-14-19-50)43-111-83(108)97-71(46(5)6)79(104)100-34-16-21-67(100)75-89-58-32-29-53(38-61(58)94-75)65-42-84-64(41-85-65)52-28-31-57-60(37-52)93-74(88-57)66-20-15-33-99(66)78(103)70(45(3)4)96-82(107)110-11/h12-14,18-19,23-32,36-42,44-47,66-72H,15-17,20-22,33-35,43H2,1-11H3,(H,86,102)(H,87,92)(H,88,93)(H,89,94)(H,90,91)(H,95,106)(H,96,107)(H,97,108)
InChIKeyQFSSNJVGVYMLQD-UHFFFAOYSA-N
MW1503.78 g/mol
LogP12.83
Rot. Bonds23

About methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 91013429) has the molecular formula C83H94N18O10 and a molecular weight of 1503.78 g/mol. Its IUPAC name is methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.

Molecular Properties

Compound Namemethyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
PubChem CID91013429
Molecular FormulaC83H94N18O10
Molecular Weight1503.78 g/mol
Exact Mass1502.74
IUPAC Namemethyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
SMILESCOC(=O)NC(C(=O)NC(C)c1nc2cc(-c3ccc(-c4ccc5nc(C6CCCN6C(=O)C(c6ccccc6)N(C)C)[nH]c5c4)cc3)c(COC(=O)NC(C(=O)N3CCCC3c3nc4ccc(-c5cnc(-c6ccc7nc(C8CCCN8C(=O)C(NC(=O)OC)C(C)C)[nH]c7c6)cn5)cc4[nH]3)C(C)C)cc2[nH]1)C(C)C
InChIInChI=1S/C83H94N18O10/c1-44(2)69(95-81(106)109-10)77(102)86-47(7)73-90-62-39-54(55(40-63(62)91-73)49-25-23-48(24-26-49)51-27-30-56-59(36-51)92-76(87-56)68-22-17-35-101(68)80(105)72(98(8)9)50-18-13-12-14-19-50)43-111-83(108)97-71(46(5)6)79(104)100-34-16-21-67(100)75-89-58-32-29-53(38-61(58)94-75)65-42-84-64(41-85-65)52-28-31-57-60(37-52)93-74(88-57)66-20-15-33-99(66)78(103)70(45(3)4)96-82(107)110-11/h12-14,18-19,23-32,36-42,44-47,66-72H,15-17,20-22,33-35,43H2,1-11H3,(H,86,102)(H,87,92)(H,88,93)(H,89,94)(H,90,91)(H,95,106)(H,96,107)(H,97,108)
InChIKeyQFSSNJVGVYMLQD-UHFFFAOYSA-N
XLogP12.83
TPSA348.76 Ų
H-Bond Donors8
H-Bond Acceptors17
Rotatable Bonds23
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001503.78
LogP ≤ 512.83
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
The IUPAC name of methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (CID 91013429) is methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
What is the SMILES notation for methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
The canonical SMILES for methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate is COC(=O)NC(C(=O)NC(C)c1nc2cc(-c3ccc(-c4ccc5nc(C6CCCN6C(=O)C(c6ccccc6)N(C)C)[nH]c5c4)cc3)c(COC(=O)NC(C(=O)N3CCCC3c3nc4ccc(-c5cnc(-c6ccc7nc(C8CCCN8C(=O)C(NC(=O)OC)C(C)C)[nH]c7c6)cn5)cc4[nH]3)C(C)C)cc2[nH]1)C(C)C.
What is the InChIKey of methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
The InChIKey is QFSSNJVGVYMLQD-UHFFFAOYSA-N. The full InChI is InChI=1S/C83H94N18O10/c1-44(2)69(95-81(106)109-10)77(102)86-47(7)73-90-62-39-54(55(40-63(62)91-73)49-25-23-48(24-26-49)51-27-30-56-59(36-51)92-76(87-56)68-22-17-35-101(68)80(105)72(98(8)9)50-18-13-12-14-19-50)43-111-83(108)97-71(46(5)6)79(104)100-34-16-21-67(100)75-89-58-32-29-53(38-61(58)94-75)65-42-84-64(41-85-65)52-28-31-57-60(37-52)93-74(88-57)66-20-15-33-99(66)78(103)70(45(3)4)96-82(107)110-11/h12-14,18-19,23-32,36-42,44-47,66-72H,15-17,20-22,33-35,43H2,1-11H3,(H,86,102)(H,87,92)(H,88,93)(H,89,94)(H,90,91)(H,95,106)(H,96,107)(H,97,108).
What are the key properties of methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate?
methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate has a molecular weight of 1503.78 g/mol, XLogP of 12.83, 23 rotatable bonds, 8 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[1-[2-[6-[5-[2-[1-[2-[[6-[4-[2-[1-[2-(dimethylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]phenyl]-2-[1-[[2-(methoxycarbonylamino)-3-methylbutanoyl]amino]ethyl]-3H-benzimidazol-5-yl]methoxycarbonylamino]-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrazin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate is sourced from PubChem (CID 91013429), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).